Environment
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
StateNew JerseyReported
A 3242: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.
Dan Hutchison
A 3242 status: Reported — Reported out of Assembly Committee, 2nd Reading (updated Sep 17, 2026).
Source
LegiScan
Confidence
High
Analysis basis
LegiScan full bill text
01
What this bill does
Official summary alongside an AI-generated read on where it stands and why.
Overall Score
77OUT OF 100
Score:77/100 civic fit
Risk:Low Risk
Impact:Moderate Impact 60/100
Constitutionality95%
Bipartisan70%
Public opinion80%
Bill summary
What changes
The bill mandates that various health insurance contracts and plans in New Jersey provide coverage for continuous glucose monitoring (CGM) systems when prescribed for the treatment of glycogen storage disease.
Who is affected
Patients with glycogen storage disease, insurance carriers, the State Health Benefits Commission, and the School Employees' Health Benefits Commission.
Requirements and enforcement
Insurers must cover CGM systems for the specified condition to the same extent as other medical conditions.
Costs and funding
Direct costs to insurers and potential premium increases for policyholders.
When it takes effect
Takes effect on the first day of the seventh month following enactment; specific implementation for individual plans on January 1, 2027.
Potential benefits
Improved health management and reduced out-of-pocket expenses for patients with this metabolic disorder.
Risks and tradeoffs
Potential for increased insurance premiums and administrative costs for coverage implementation.
What is still unknown
The exact impact on insurance premiums for New Jersey residents.
02
Impact analysis
✦ AI analysisModeled effects across six domains, estimated from bill text and comparable legislation.
Economy
Mixed / Neutral
45%
Benefits
- Reduces out-of-pocket costs for patients requiring CGM technology.
- Potentially lowers long-term costs by preventing emergency medical interventions.
- Provides clear coverage standards for healthcare providers and insurers.
Risks
- Increases administrative and compliance costs for insurance providers.
- May lead to upward pressure on insurance premiums due to added coverage requirements.
- Imposes new fiscal obligations on the State Health Benefits Commission.
Society
Positive outlook
90%
Benefits
- Improves access to essential medical technology for rare disease patients.
- Enhances quality of life for individuals with glycogen storage disease.
- Reduces financial barriers to necessary chronic condition management.
Risks
- Availability remains dependent on prescription by a healthcare practitioner.
- Does not address barriers beyond insurance coverage, such as supply shortages.
- Impact is limited to a narrow group of patients with this specific disease.
Technology Industry
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Civic Accountability
No direct effect
Neutral — no direct effect identified.
Benefits
- No material direct effect identified.
Risks
- No material direct effect identified.
Public Health & Safety
Positive outlook
95%
Benefits
- Enables constant blood glucose monitoring, critical for glycogen storage disease.
- Facilitates rapid clinical response to life-threatening hypoglycemic events.
- Supports better adherence to medical protocols for metabolic regulation.
Risks
- Dependent on the patient's adherence to using the prescribed CGM system.
- Safety efficacy relies on the accuracy of the underlying monitoring hardware.
- Potential for alarm fatigue if monitoring systems are not calibrated correctly.
03
How trustworthy & consequential it is
Sourcing already shown above, this is what the analysis found worth flagging.
Source
LegiScan
Official bill text or data from LegiScan.
Confidence
High
Information is complete and verified.
Analysis basis
LegiScan full bill text
Source used for this bill's analysis.
Source note
Requires insurance carriers to adjust coverage policies, which may impact premiums.
Analysis scope
Economic impact estimates on premiums are not provided in the text.
04
Where it stands
Official record- IntroducedComplete
- CommitteeCurrent
- Chamber votesUpcoming
- Final agreementUpcoming
- GovernorUpcoming
- EnactedUpcoming
05
How it affects your district
✦ Personalized
Set your location
Add your district to see how this bill may affect your community and who to contact.
Your Representatives
Your representatives appear here once you add your location.
06
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.